Small Irvine business BioDot, working to support COVID-19 test manufacturers globally
For over 26 years, BioDot, Irvine CA has produced low volume liquid handling equipment for precious reagents like DNA and antibodies used in diagnostic testing devices. BioDot's technologies and systems stand behind some of the biggest names in rapid diagnostic tests today.
Why are Rapid Tests Important?
Rapid tests supply our frontline caregivers a needed tool in fighting the coronavirus outbreak. Simple tests taking less than 15 minutes, performed at the patient's bedside, confirming if a patient has COVID-19 allows doctors to make informed care decisions. Some of these test formats are immunochromatographic assays more commonly known as lateral flow tests. An over the counter pregnancy test is a common example of this format.
These immunoassays are used to identify whether people have been exposed to the virus by looking for an immune response. Only a few of these tests have been approved for use by governments around the world but many more are in the process of being reviewed. Demand for SARS-CoV-2 lateral flow tests is growing daily and expected to increase throughout the coming months.
How is BioDot Helping?
BioDot has been able to respond to the growing rapid test demand with products for lateral flow test manufacturing as well as other formats. "Our team is very proud of the contribution that our products are making in this global healthcare fight. We have been working closely with test developers to quickly bring on increased manufacturing capabilities," comments Kelly Tisone, VP Marketing. "During this critical period BioDot has been able to continue operations and is dedicated to meet the growing demand."
BioDot manufactures all of its products at their headquarters in Irvine. In addition, sales and service offices are located in the UK and China.
2852 Alton Parkway, Irvine CA 92606
Founded in 1994, BioDot manufactures precision low volume fluid dispensing systems. Today with over 5000 units in the field BioDot is one of the largest suppliers of equipment in the diagnostic test market. BioDot's portfolio of proprietary dispensing technologies and wide range of platforms serves customers from R&D through high volume manufacturing in the industrial, diagnostic, life science and medical product markets. Today BioDot holds over 26 global patents in the area of low volume dispensing and novel applications. BioDot is a worldwide company with offices in China and the United Kingdom. BioDot's long-lasting relationships with customers is built on precision products and quality service around the world.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Small Irvine business BioDot, working to support COVID-19 test manufacturers globally here
News-ID: 2002730 • Views: …
More Releases for Irvine
Global Infertility Market 2019 - Irvine Scientific, Ivftech, The Baker Company, …
Apex Market Reports, recently published a detailed market research study focused on the “Infertility Market” across the global, regional and country level. The report provides 360° analysis of “Infertility Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Infertility on the basis of
InVitro Fertilization (IVF) Market Size: Irvine Scientific, GeneaBiomedx, Cooper …
Qyresearchreports include new market research report “Global InVitro Fertilization (IVF) Market Size, Status and Forecast 2025” to its huge collection of research reports. This report focuses on the top players in global market, like Vitrolife AB Merck Serono Ferring Pharmaceuticals Irvine Scientific GeneaBiomedx Cooper Surgical Origio Genea Halotech Dna Auxilium Pharmaceuticals Auxogyn Ovascience Andrology Solutions Download Free exclusive Sample of this report: https://www.qyresearchreports.com/sample/sample.php?rep_id=1635929&type=S The report on the global market for InVitro Fertilization (IVF) has been prepared after conducting a fructuous analysis of several industries aligned with
Global Airport Friction Tester Market 2018 - ASFT, Dynatest, FINDLAY IRVINE, OLS …
Apex Market Reports, recently published a detailed market research study focused on the “Airport Friction Tester Market” across the global, regional and country level. The report provides 360° analysis of “Airport Friction Tester Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Airport
Global Assisted Reproductive Technology (ART) Market 2017 Key Players -Merck & C …
Assisted Reproductive Technology (ART) Market: WiseGuyReports.com adds “Assisted Reproductive Technology (ART) Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database. Executive Summary Infertility is a medical condition characterized by inability to achieve pregnancy. The problem has aggravated in many parts of the world underscoring the need for technological prowess to address the issue. Advancement in medical technology has brought forth Assisted Reproductive Technology (ART) which is
PAS-X Information Nucleus at B. Braun Irvine
PAS-X Information Nucleus at B. Braun Irvine US site implements sophisticated multi-level IT architecture with Werum’s PAS-X Lueneburg, Germany, 12 June 2012 – B. Braun’s facility in Irvine, CA is currently installing a new, highly automated production line, with Werum’s PAS-X as a core component. The line, designed to produce a variety of IV Solution bags for hospitals and clinics, will manufacture the empty bags, fill them, sterilize them, and package them,
Irvine Company's 2010 New Home Collection
Inspired by extensive research about what consumers want when they purchase a new home - and responding to pent-up demand for new housing - the Irvine Company is set to debut a collection of new homes that will begin selling early next year. Known as "The 2010 New Home Collection," the series of 25 floor plans from six different builders will be located throughout eight neighborhoods in Woodbury and Woodbury